The mean treatment effect of glycopyrronium was greater than the minimum clinically important difference versus placebo in both St George 's Respiratory Questionnaire total score ( -4.92 ; P < 0.001 ) and Transition Dyspnea Index focal score ( 1.0 ; P < 0.001 ) at week 26 .